Literature DB >> 8693514

Hemolytic anemia in chronic large granular lymphocytic leukemia of natural killer cells: cytotoxicity of natural killer cells against autologous red cells is associated with hemolysis.

F Gilsanz1, J De La Serna, L Moltó, M Alvarez-Mon.   

Abstract

BACKGROUND: It has ben suggested that natural killer cells are effectors in some hemolytic transfusion reactions, but a direct mechanism of the destruction of red cells has not been demonstrated. CASE REPORT: Lytic activity of natural killer cells against autologous red cells was found in a patient with large granular lymphocytic leukemia of natural killer cells and hemolytic anemia, with no evidence of immune antibody or complement-mediated hemolysis. Large granular lymphocytes in the blood showed a CD2+ CD3- CD16+ CD57+ phenotype, cytotoxic activity against natural killer cell-sensitive K562 target cells, and no lytic activity against natural killer cell-resistant JY target cells. Cytotoxicity directed against red cells was quantified by a 51Cr-specific release assay with autologous and ABO-identical red cells used as target cells and the patients purified natural killer cells used as effector cells in the presence and absence of autologous serum. The cytotoxic activity of natural killer cells was directed against autologous red cells but not against allogenic red cells, and it was not enhanced by the presence of autologous serum in the medium. Clinical remission was induced by the administration of cyclophosphamide, after which no evidence of cytotoxic activity against the red cells could be found.
CONCLUSION: Hemolytic anemia in the presence of a negative direct antiglobulin test can be attributed to a direct cytotoxic mechanism mediated by natural killer cells.

Entities:  

Mesh:

Year:  1996        PMID: 8693514     DOI: 10.1046/j.1537-2995.1996.36596338025.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.

Authors:  Margarida Lima; Julia Almeida; Andrés García Montero; Maria dos Anjos Teixeira; Maria Luís Queirós; Ana Helena Santos; Ana Balanzategui; Alexandra Estevinho; Maria del Cármen Algueró; Paloma Barcena; Sónia Fonseca; Maria Luís Amorim; José Manuel Cabeda; Luciana Pinho; Marcos Gonzalez; Jesus San Miguel; Benvindo Justiça; Alberto Orfão
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

2.  Blood transfusion promotes cancer progression: a critical role for aged erythrocytes.

Authors:  Shir Atzil; Michal Arad; Ariella Glasner; Noa Abiri; Roi Avraham; Keren Greenfeld; Ella Rosenne; Benzion Beilin; Shamgar Ben-Eliyahu
Journal:  Anesthesiology       Date:  2008-12       Impact factor: 7.892

Review 3.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 4.  Role of Complement in Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

Review 5.  New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia.

Authors:  Wilma Barcellini
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

6.  Hyperhemolysis in a patient with beta-thalassemia major.

Authors:  Lakmali R Morawakage; B J C Perera; P D N Dias; S K Wijewardana
Journal:  Asian J Transfus Sci       Date:  2009-01

7.  Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition.

Authors:  Savannah Mwesigwa; Joann M Moulds; Alice Chen; Jonathan Flanagan; Vivien A Sheehan; Alex George; Neil A Hanchard
Journal:  Transfusion       Date:  2017-12-06       Impact factor: 3.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.